111 (YI) Debt Ratio (2019 - 2025)

111 (YI) reported Debt Ratio of 0.09 for Q4 2025, up 47.68% on a YoY basis from 0.06 in Q4 2024, and up 47.68% sequentially from 0.06 in Q4 2024.

111 (YI) Debt Ratio (2019 - 2025) Analysis & Trends

111 (YI) has 7 years of Debt Ratio data on file, last reported at 0.09 in Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio rose 47.68% year-over-year to 0.09; the trailing twelve-month figure through Dec 2025 stood at 0.09 (up 47.68% YoY), and the FY2025 full-year result was 0.08, up 43.71% from the prior year.
  • Debt Ratio advanced to 0.09 in Q4 2025, from 0.06 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.11 in Q4 2023 to a low of 0.05 in Q4 2022.
  • A 5-year average of 0.08 and a median of 0.08 in 2021 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio surged 112.41% in 2023 and tumbled 47.24% in 2024, its largest moves.
  • Tracing YI's Debt Ratio over 5 years: stood at 0.08 in 2021, then tumbled by 37.58% to 0.05 in 2022, then surged by 112.41% to 0.11 in 2023, then slumped by 47.24% to 0.06 in 2024, then surged by 47.68% to 0.09 in 2025.
  • Business Quant data shows YI's Debt Ratio at 0.09 in Q4 2025, 0.06 in Q4 2024, and 0.11 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Mckesson 105.15 Bn 101.18 Bn 4.04 Bn 0.08
2 Cencora 60.58 Bn 58.40 Bn 3.59 Bn 0.15
3 Cardinal Health 53.81 Bn 49.87 Bn 2.50 Bn 0.16
4 Henry Schein 9.71 Bn 9.57 Bn 1.07 Bn 0.30
5 Akso Health 3.28 Bn 3.28 Bn - 0.00
6 111 651.73 Mn 572.63 Mn 23.58 Mn 0.09
7 Accendra Health 248.02 Mn -88.86 Mn 278.03 Mn 0.87
8 Edap Tms 230.14 Mn 215.14 Mn 8.15 Mn 0.26
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00 -
10 Cosmos Health 9.57 Mn 7.41 Mn 1.38 Mn 0.15

Historic Data

Download Data
DateValue
Dec 31, 2025 0.09
Dec 31, 2024 0.06
Dec 31, 2023 0.11
Dec 31, 2022 0.05
Dec 31, 2021 0.08
Dec 31, 2020 0.08
Dec 31, 2019 0.02